Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.

Journal of neuroimmunology - 1 May 2007

Ramagopalan S V, Deluca G C, Morrison K M, Herrera B M, Dyment D A, Orton S, Bihoreau M T, Degenhardt A, Pugliatti M, Sadovnick A D, Sotgiu S, Ebers G C

Abstract excerpt

Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Apolipoprotein E (APOE) is involved in neuronal remodelling and several studies have attempted to examine the effect of APOE on MS disease severity, but its function in modifying the course of MS is controversial. It has been suggested recently that PVRL2, not APOE, is the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Cell Adhesion Molecules

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Gene Frequency

Share to Genotype

Share to Multiple Sclerosis

Share to Nectins

Share to Severity of Illness Index

Source

Identifiers

PMID: 17376543
DOI: 10.1016/j.jneuroim.2007.02.003

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.PMID 17376543Read ↗

Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.Semantic proximity Read ↗

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.Semantic proximity Read ↗

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.Semantic proximity Read ↗

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.Semantic proximity Read ↗

APOE genotypes and disease severity in multiple sclerosis.Semantic proximity Read ↗

ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.Semantic proximity Read ↗

Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis.Semantic proximity Read ↗

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.Semantic proximity Read ↗

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele.Semantic proximity Read ↗

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.Semantic proximity Read ↗

Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.Semantic proximity Read ↗

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.